FDA Inspection 676852 — CP Pharmaceuticals Limited
The FDA completed an inspection of CP Pharmaceuticals Limited on July 29, 2010 in Wrexham. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- July 29, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Wrexham (United Kingdom)